Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 2
2007 4
2008 1
2009 2
2011 10
2012 2
2013 6
2014 9
2015 6
2016 11
2017 3
2018 7
2019 11
2020 6
2021 14
2022 15
2023 18
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

123 results

Results by year

Filters applied: . Clear all
Page 1
Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trial.
Thompson GR 3rd, Soriano A, Cornely OA, Kullberg BJ, Kollef M, Vazquez J, Honore PM, Bassetti M, Pullman J, Chayakulkeeree M, Poromanski I, Dignani C, Das AF, Sandison T, Pappas PG; ReSTORE trial investigators. Thompson GR 3rd, et al. Lancet. 2023 Jan 7;401(10370):49-59. doi: 10.1016/S0140-6736(22)02324-8. Epub 2022 Nov 25. Lancet. 2023. PMID: 36442484 Clinical Trial.
Impact of gut microbiota on kidney transplantation.
Winichakoon P, Chaiwarith R, Chattipakorn N, Chattipakorn SC. Winichakoon P, et al. Among authors: chaiwarith r. Transplant Rev (Orlando). 2022 Jan;36(1):100668. doi: 10.1016/j.trre.2021.100668. Epub 2021 Oct 18. Transplant Rev (Orlando). 2022. PMID: 34688985 Review.
Safety and immunogenicity of the third and fourth doses of vaccine against SARS-CoV-2 following a 2-dose regimen of inactivated whole-virion SARS-CoV-2 vaccine.
Chaiwarith R, Winichakoon P, Salee P, Sudjaritruk T, Wipasa J, Chawansuntati K, Yasri S, Thongwitokomarn H, Krasaewes K, Ruangsirinusorn S, Praparattanapan J, Solai N, Nuket K, Boonmee D, Chaichana O, Mueangmo O, Saheng J, Wongjak W. Chaiwarith R, et al. Sci Rep. 2023 Nov 13;13(1):19736. doi: 10.1038/s41598-023-45735-7. Sci Rep. 2023. PMID: 37957189 Free PMC article.
Service delivery challenges in HIV care during the first year of the COVID-19 pandemic: results from a site assessment survey across the global IeDEA consortium.
Brazier E, Ajeh R, Maruri F, Musick B, Freeman A, Wester CW, Lee MP, Shamu T, Crabtree Ramírez B, d'Almeida M, Wools-Kaloustian K, Kumarasamy N, Althoff KN, Twizere C, Grinsztejn B, Tanser F, Messou E, Byakwaga H, Duda SN, Nash D; International epidemiology Databases to Evaluate AIDS. Brazier E, et al. J Int AIDS Soc. 2022 Dec;25(12):e26036. doi: 10.1002/jia2.26036. J Int AIDS Soc. 2022. PMID: 36504431 Free PMC article.
SERPINA1, generalized pustular psoriasis, and adult-onset immunodeficiency.
Kantaputra P, Chaowattanapanit S, Kiratikanon S, Chaiwarith R, Choonhakarn C, Intachai W, Quarto N, Tongsima S, Ketudat Cairns JR, Ngamphiw C, McGrath JA, Chuamanochan M. Kantaputra P, et al. Among authors: chaiwarith r. J Dermatol. 2021 Oct;48(10):1597-1601. doi: 10.1111/1346-8138.16081. Epub 2021 Aug 12. J Dermatol. 2021. PMID: 34390020
Immunogenicity and safety of SARS-CoV-2 recombinant protein nanoparticle vaccine GBP510 adjuvanted with AS03: interim results of a randomised, active-controlled, observer-blinded, phase 3 trial.
Song JY, Choi WS, Heo JY, Kim EJ, Lee JS, Jung DS, Kim SW, Park KH, Eom JS, Jeong SJ, Lee J, Kwon KT, Choi HJ, Sohn JW, Kim YK, Yoo BW, Jang IJ, Capeding MZ, Roman F, Breuer T, Wysocki P, Carter L, Sahastrabuddhe S, Song M, D'Cor N, Kim H, Ryu JH, Lee SJ, Park YW, Cheong HJ; GBP510/AS03 study group. Song JY, et al. EClinicalMedicine. 2023 Sep 7;64:102140. doi: 10.1016/j.eclinm.2023.102140. eCollection 2023 Oct. EClinicalMedicine. 2023. PMID: 37711219 Free PMC article.
123 results